Cargando…
Early and Midterm Major Adverse Cardiac Events in Patient With Saphenous Vein Graft Using Direct Stenting or Embolic Protection Device Stenting
BACKGROUND: The treatment of an occluded saphenous vein graft (SVG) with percutaneous coronary intervention may encounter major adverse cardiac events (MACE). MACE rates have been reduced significantly by using the embolic protection device (EPD). OBJECTIVES: The aim of this study was to clarify the...
Autores principales: | Sadr-Ameli, Mohammadali, Mousavi, Hossein, Heidarali, Mona, Maadani, Mohsen, Ghelich, Yones, Ghadrdoost, Behshid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253743/ https://www.ncbi.nlm.nih.gov/pubmed/25478526 http://dx.doi.org/10.5812/cardiovascmed.13012 |
Ejemplares similares
-
Neointima development in externally stented saphenous vein grafts
por: Węglarz, Przemysław, et al.
Publicado: (2016) -
Diagnostic Accuracy of Post Procedural Creatine Kinase, MB Form can Predict Long-Term Outcomes in Patients Undergoing Selective Percutaneous Coronary Intervention?
por: Maadani, Mohsen, et al.
Publicado: (2014) -
Neointima development in externally stented saphenous vein grafts. External stents are bad for the patient: why not use an undamaged saphenous vein for coronary artery bypass graft?
por: Dashwood, Michael R., et al.
Publicado: (2017) -
Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent
por: Papadopoulos, Kyriacos, et al.
Publicado: (2021) -
Early and Midterm Outcomes of “No-Touch” Saphenous Vein Grafts in
Japanese Institutions
por: Tsuneyoshi, Hiroshi, et al.
Publicado: (2022)